loading page

Spliced HLA bound peptides; a Black-Swan event in Immunology
  • Pouya Faridi,
  • Mohammadreza .Dorvash,
  • Anthony Purcell
Pouya Faridi
Monash University

Corresponding Author:pouya.faridi@monash.edu

Author Profile
Mohammadreza .Dorvash
Monash University
Author Profile
Anthony Purcell
Monash University
Author Profile

Abstract

Peptides that bind to and are presented on the cell surface by Human Leukocyte Antigens (HLA) molecules play a critical role in adaptive immunity. For a long time, it was believed all of the HLA bound peptides were generated through simple proteolysis of linear sequences of cellular proteins, and therefore, are templated in the genome and proteome. However, evidence for untemplated peptide ligands of HLA molecules has accumulated over the last two decades, with a recent global analysis of HLA-bound peptides suggesting that a considerable proportion of HLA bound peptides are potentially generated through splicing/fusion of discontinuous peptide segments from one or two distinct proteins. In this review, we will review recent discoveries and debates on the contribution of spliced peptides to the HLA class I immunopeptidome, consider biochemical rules for splicing, and the potential role of these spliced peptides in immune recognition.
24 Dec 2020Submitted to Clinical & Experimental Immunology
04 Jan 2021Submission Checks Completed
04 Jan 2021Assigned to Editor
04 Jan 2021Reviewer(s) Assigned
16 Jan 2021Review(s) Completed, Editorial Evaluation Pending
18 Jan 2021Editorial Decision: Revise Minor
20 Feb 20211st Revision Received
22 Feb 2021Review(s) Completed, Editorial Evaluation Pending
22 Feb 2021Editorial Decision: Accept
23 Apr 2021Published in Clinical and Experimental Immunology volume 204 issue 2 on pages 179-188. 10.1111/cei.13589